Concord Biotech completes Russian GMP inspection

28 Jul 2025 Evaluate

Concord Biotech has successfully completed the Russian GMP (Good Manufacturing Practice) inspection. The inspection was conducted at company's Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 22, 2025 to July 25, 2025.

The development highlights company’s commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of the operations.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1339.30 171.70 (14.71%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×